drugset / Trial / NCT01134926

Non Surgical Management for Uterine Residua After Pregnancy Termination, Abortion or Delivery

NCT01134926 ↗

Phase 2 Terminated 23 enrolled HaEmek Medical Center, Israel
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to find out whether conservative treatment - expectant management or medical therapy using misoprostol is beneficial in the case of uterine residua, and which treatment is better.

Timeline

Start
2010-06
Primary completion
2012-05
Completion
2012-05

Outcome

Outcome not reported

Stopped: “The principal investigator left the organization”

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified — Other

Indications